NEUREN PHARMACEUTICALS LIMITED
Markets News
Markets
Market Close
Spark share collapse leads NZ sharemarket down
The S&P/NZX 50 Index closed down 0.99% or 127.78 points.
Markets
Spark valuation plummets $1 billion as profit crashes
Spark has reported a 78% fall in net profit to $35 million in the first half of its 2025 financial year and reduced its full-year operating earnings guidance. However, it has maintained its revised full-year dividend guidance.Shares – already down 42% over the past year after two...
Markets
BusinessDesk Explains
The good, the bad, and the ugly of share buybacks
Spark did one, Fletcher did too and now Air NZ is. What are share buy-backs?
Markets
Market Close
NZ sharemarket down 1.2% as earnings season hits full swing
The S&P/NZX 50 Index closed at 12.880.36, down 153.00 points or 1.17%.
